0 items USD 0.00Search
Your search for "lpi 2017 2022 malaysia luxury hotels market report status outlook" gave back 33670 results.
Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
VYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, The global Vyxeos market was valued at...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Panhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hemin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Arranon is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Arranon market was valued at US$ 79 million in 2023 and is...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Nelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Nelarabine market was valued at US$ 134 million in 2023 and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Allergy Immunotherapies market size was valued at US$ million in 2023. With growing demand in downstream market, the Allergy...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
